Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of an SGLT2 inhibitor for biological aging
jRCTs031250234Recruiting
- Sponsor
- AMED Moonshot Research and Development Program
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of empagliflozin in Ageing (2 arms), sponsored by AMED Moonshot Research and Development Program. Primary endpoint: Change in biological age by GrimAge version 2. Started Nov 2025; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
Ageing
Beyond the preview
Go deeper on jRCTs031250234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250234.